2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:10791 6480464 Tetrachlorodibenzodioxin results in decreased expression of IL1RAP mRNA CTD PMID:19933214 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:10791 6480464 Tetrachlorodibenzodioxin affects the expression of IL1RAP mRNA CTD PMID:21570461 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of IL1RAP mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of IL1RAP mRNA CTD PMID:21346803 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO RGD:10791 6480464 3 more ... CTD PMID:19467301 3,4-methylenedioxymethamphetamine increases expression ISO RGD:10791 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of IL1RAP mRNA CTD PMID:20188158 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:732294 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of IL1RAP mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of IL1RAP mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions ISO RGD:732294 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of IL1RAP mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol increases expression ISO RGD:10791 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of IL1RAP mRNA CTD PMID:30951980 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid decreases expression ISO RGD:732294 6480464 Am 580 results in decreased expression of IL1RAP mRNA CTD PMID:16982809 4-hydroxyphenyl retinamide decreases expression ISO RGD:10791 6480464 Fenretinide results in decreased expression of IL1RAP mRNA CTD PMID:28973697 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of IL1RAP mRNA CTD PMID:24780913 aflatoxin B1 decreases expression ISO RGD:10791 6480464 Aflatoxin B1 results in decreased expression of IL1RAP mRNA CTD PMID:19770486 aflatoxin B1 increases methylation ISO RGD:732294 6480464 Aflatoxin B1 results in increased methylation of IL1RAP intron CTD PMID:30157460 aflatoxin B1 decreases methylation ISO RGD:732294 6480464 Aflatoxin B1 results in decreased methylation of IL1RAP gene CTD PMID:27153756 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of IL1RAP mRNA CTD PMID:16483693 antirheumatic drug decreases expression ISO RGD:732294 6480464 Antirheumatic Agents results in decreased expression of IL1RAP mRNA CTD PMID:24449571 arsane affects expression ISO RGD:732294 6480464 Arsenic affects the expression of IL1RAP protein CTD PMID:24675094 arsane affects methylation ISO RGD:732294 6480464 Arsenic affects the methylation of IL1RAP gene CTD PMID:25304211 arsenic atom affects expression ISO RGD:732294 6480464 Arsenic affects the expression of IL1RAP protein CTD PMID:24675094 arsenic atom affects methylation ISO RGD:732294 6480464 Arsenic affects the methylation of IL1RAP gene CTD PMID:25304211 arsenite(3-) multiple interactions ISO RGD:10791 6480464 [arsenite co-treated with Benzo(a)pyrene] results in decreased expression of IL1RAP mRNA CTD PMID:15894712 arsenite(3-) decreases expression ISO RGD:10791 6480464 arsenite results in decreased expression of IL1RAP mRNA CTD PMID:15894712 benzo[a]pyrene decreases expression ISO RGD:10791 6480464 Benzo(a)pyrene results in decreased expression of IL1RAP mRNA CTD PMID:15894712 , PMID:19770486 benzo[a]pyrene multiple interactions ISO RGD:10791 6480464 [arsenite co-treated with Benzo(a)pyrene] results in decreased expression of IL1RAP mRNA CTD PMID:15894712 benzo[e]pyrene increases methylation ISO RGD:732294 6480464 benzo(e)pyrene results in increased methylation of IL1RAP intron CTD PMID:30157460 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:10791 6480464 Diethylhexyl Phthalate results in decreased expression of IL1RAP mRNA CTD PMID:19850644 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:10791 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in decreased expression of IL1RAP mRNA] CTD PMID:19850644 bisphenol A decreases expression ISO RGD:732294 6480464 bisphenol A results in decreased expression of IL1RAP mRNA CTD PMID:20678512 bisphenol A increases expression ISO RGD:10791 6480464 bisphenol A results in increased expression of IL1RAP mRNA CTD PMID:30951980 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of IL1RAP gene CTD PMID:28505145 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of IL1RAP mRNA CTD PMID:25181051 bisphenol F multiple interactions ISO RGD:732294 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of IL1RAP mRNA CTD PMID:28628672 bisphenol F increases expression ISO RGD:10791 6480464 bisphenol F results in increased expression of IL1RAP mRNA CTD PMID:30951980 cadmium atom increases expression ISO RGD:732294 6480464 Cadmium results in increased expression of IL1RAP mRNA CTD PMID:22562489 cadmium selenide multiple interactions ISO RGD:732294 6480464 [cadmium selenide co-treated with zinc sulfide] results in increased expression of IL1RAP mRNA CTD PMID:22342292 calcitriol increases expression ISO RGD:732294 6480464 Calcitriol results in increased expression of IL1RAP mRNA CTD PMID:26485663 ciprofibrate decreases expression ISO RGD:10791 6480464 ciprofibrate results in decreased expression of IL1RAP mRNA CTD PMID:12771043 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of IL1RAP mRNA CTD PMID:22023808 cisplatin increases expression ISO RGD:732294 6480464 Cisplatin results in increased expression of IL1RAP mRNA CTD PMID:27392435 copper(II) sulfate decreases expression ISO RGD:732294 6480464 Copper Sulfate results in decreased expression of IL1RAP mRNA CTD PMID:19549813 crocidolite asbestos increases expression ISO RGD:10791 6480464 Asbestos, Crocidolite results in increased expression of IL1RAP mRNA CTD PMID:19446018 crocidolite asbestos decreases expression ISO RGD:732294 6480464 Asbestos, Crocidolite results in decreased expression of IL1RAP mRNA CTD PMID:29523930 cyclosporin A decreases expression ISO RGD:732294 6480464 Cyclosporine results in decreased expression of IL1RAP mRNA CTD PMID:27989131 cyproconazole decreases expression ISO RGD:10791 6480464 cyproconazole results in decreased expression of IL1RAP mRNA CTD PMID:22334560 dexamethasone multiple interactions ISO RGD:732294 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of IL1RAP mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of IL1RAP mRNA CTD PMID:28628672 dorsomorphin multiple interactions ISO RGD:732294 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of IL1RAP mRNA CTD PMID:27181935 doxorubicin multiple interactions EXP 6480464 Fungal Polysaccharides inhibits the reaction [Doxorubicin results in increased expression of IL1RAP mRNA] CTD PMID:27181935 epoxiconazole decreases expression ISO RGD:10791 6480464 epoxiconazole results in decreased expression of IL1RAP mRNA CTD PMID:22334560 erlotinib hydrochloride multiple interactions ISO RGD:732294 6480464 [Erlotinib Hydrochloride results in decreased susceptibility to Erlotinib Hydrochloride] which results in increased expression of IL1RAP mRNA CTD PMID:27738319 ethanol affects splicing ISO RGD:10791 6480464 Ethanol affects the splicing of IL1RAP mRNA CTD PMID:30319688 ethyl methanesulfonate increases expression ISO RGD:732294 6480464 Ethyl Methanesulfonate results in increased expression of IL1RAP mRNA CTD PMID:23649840 fenamidone increases expression ISO RGD:10791 6480464 fenamidone results in increased expression of IL1RAP mRNA CTD PMID:27029645 flavonoids increases expression EXP 6480464 Flavonoids results in increased expression of IL1RAP mRNA CTD PMID:18035473 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of IL1RAP mRNA CTD PMID:24136188 imiquimod increases expression ISO RGD:10791 6480464 Imiquimod results in increased expression of IL1RAP mRNA CTD PMID:31054998 indometacin multiple interactions ISO RGD:732294 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of IL1RAP mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of IL1RAP mRNA CTD PMID:28628672 lead(0) affects expression ISO RGD:732294 6480464 Lead affects the expression of IL1RAP mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:732294 6480464 Lead affects the expression of IL1RAP mRNA CTD PMID:28903495 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of IL1RAP mRNA CTD PMID:24136188 lipopolysaccharide increases expression ISO RGD:10791 6480464 Lipopolysaccharides results in increased expression of IL1RAP mRNA CTD PMID:17321000 lipopolysaccharide decreases expression ISO RGD:732294 6480464 Lipopolysaccharides results in decreased expression of IL1RAP mRNA CTD PMID:31059760 lipopolysaccharide multiple interactions ISO RGD:732294 6480464 [Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of IL1RAP mRNA CTD PMID:31059760 mercury dibromide multiple interactions ISO RGD:732294 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IL1RAP mRNA CTD PMID:27188386 methapyrilene increases methylation ISO RGD:732294 6480464 Methapyrilene results in increased methylation of IL1RAP intron CTD PMID:30157460 methyl methanesulfonate increases expression ISO RGD:732294 6480464 Methyl Methanesulfonate results in increased expression of IL1RAP mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO RGD:732294 6480464 methylmercuric chloride results in decreased expression of IL1RAP mRNA CTD PMID:28001369 N-methylformamide decreases expression ISO RGD:10791 6480464 methylformamide analog results in decreased expression of IL1RAP mRNA, methylformamide results in decreased expression of IL1RAP mRNA CTD PMID:17040096 N-nitrosodiethylamine decreases expression ISO RGD:10791 6480464 Diethylnitrosamine results in decreased expression of IL1RAP mRNA CTD PMID:12771043 nickel atom increases expression ISO RGD:732294 6480464 Nickel results in increased expression of IL1RAP mRNA CTD PMID:25583101 nitrobenzenes decreases expression EXP 6480464 Nitrobenzenes analog results in decreased expression of IL1RAP mRNA CTD PMID:19784758 omega-6 fatty acid increases expression ISO RGD:732294 6480464 Fatty Acids, Omega-6 results in increased expression of IL1RAP mRNA CTD PMID:16823509 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of IL1RAP mRNA CTD PMID:25729387 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of IL1RAP mRNA CTD PMID:19784758 paracetamol multiple interactions ISO RGD:732294 6480464 [Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of IL1RAP mRNA CTD PMID:31059760 paracetamol increases expression ISO RGD:732294 6480464 Acetaminophen results in increased expression of IL1RAP mRNA CTD PMID:29067470 paracetamol decreases expression ISO RGD:732294 6480464 Acetaminophen results in decreased expression of IL1RAP mRNA CTD PMID:31059760 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of IL1RAP mRNA CTD PMID:19784758 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of IL1RAP mRNA CTD PMID:19784758 phenobarbital affects expression ISO RGD:10791 6480464 Phenobarbital affects the expression of IL1RAP mRNA CTD PMID:23091169 phenylmercury acetate multiple interactions ISO RGD:732294 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IL1RAP mRNA CTD PMID:27188386 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:732294 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of IL1RAP mRNA CTD PMID:16979875 pinosylvin decreases expression ISO RGD:732294 6480464 pinosylvin results in decreased expression of IL1RAP mRNA CTD PMID:23333577 pirinixic acid multiple interactions ISO RGD:10791 6480464 [pirinixic acid co-treated with PPARA] results in decreased expression of IL1RAP mRNA, PPARA protein affects the reaction [pirinixic acid results in decreased expression of IL1RAP mRNA] CTD PMID:17321000 , PMID:20813756 pirinixic acid decreases expression ISO RGD:10791 6480464 pirinixic acid results in decreased expression of IL1RAP mRNA CTD PMID:17321000 more ... potassium chromate decreases expression ISO RGD:732294 6480464 potassium chromate(VI) results in decreased expression of IL1RAP mRNA CTD PMID:22714537 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:10791 6480464 Pregnenolone Carbonitrile results in decreased expression of IL1RAP mRNA CTD PMID:28903501 propiconazole decreases expression ISO RGD:10791 6480464 propiconazole results in decreased expression of IL1RAP mRNA CTD PMID:22334560 quercetin increases expression ISO RGD:732294 6480464 Quercetin results in increased expression of IL1RAP mRNA CTD PMID:30152185 raloxifene affects expression ISO RGD:732294 6480464 Raloxifene Hydrochloride affects the expression of IL1RAP mRNA CTD PMID:14699072 rotenone increases expression ISO RGD:10791 6480464 Rotenone results in increased expression of IL1RAP mRNA CTD PMID:23186747 SB 431542 multiple interactions ISO RGD:732294 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silver atom increases expression ISO RGD:732294 6480464 Silver results in increased expression of IL1RAP mRNA CTD PMID:22342292 silver atom decreases expression ISO RGD:10791 6480464 Silver results in decreased expression of IL1RAP mRNA CTD PMID:27131904 silver(0) increases expression ISO RGD:732294 6480464 Silver results in increased expression of IL1RAP mRNA CTD PMID:22342292 silver(0) decreases expression ISO RGD:10791 6480464 Silver results in decreased expression of IL1RAP mRNA CTD PMID:27131904 Soman increases expression EXP 6480464 Soman results in increased expression of IL1RAP mRNA CTD PMID:19281266 tetrachloromethane decreases expression ISO RGD:10791 6480464 Carbon Tetrachloride results in decreased expression of IL1RAP mRNA CTD PMID:17084009 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of IL1RAP mRNA CTD PMID:19784758 tetrachloromethane multiple interactions ISO RGD:10791 6480464 CYP2E1 gene mutant form inhibits the reaction [Carbon Tetrachloride results in decreased expression of IL1RAP mRNA] CTD PMID:17084009 tetrachloromethane affects expression ISO RGD:10791 6480464 Carbon Tetrachloride affects the expression of IL1RAP mRNA CTD PMID:17484886 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of IL1RAP mRNA CTD PMID:19784758 , PMID:23411599 titanium dioxide increases expression ISO RGD:732294 6480464 titanium dioxide results in increased expression of IL1RAP mRNA CTD PMID:22342292 topotecan increases expression EXP 6480464 Topotecan results in increased expression of IL1RAP mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of IL1RAP mRNA CTD PMID:25729387 trans-pinosylvin decreases expression ISO RGD:732294 6480464 pinosylvin results in decreased expression of IL1RAP mRNA CTD PMID:23333577 trichloroethene affects expression ISO RGD:10791 6480464 Trichloroethylene affects the expression of IL1RAP mRNA CTD PMID:21135412 troglitazone decreases expression ISO RGD:10791 6480464 troglitazone results in decreased expression of IL1RAP mRNA CTD PMID:28973697 valproic acid increases expression ISO RGD:732294 6480464 Valproic Acid results in increased expression of IL1RAP mRNA CTD PMID:23179753 more ... valproic acid decreases methylation ISO RGD:732294 6480464 Valproic Acid results in decreased methylation of IL1RAP gene CTD PMID:29154799 valproic acid affects expression ISO RGD:732294 6480464 Valproic Acid affects the expression of IL1RAP mRNA CTD PMID:25979313 vorinostat increases expression ISO RGD:732294 6480464 vorinostat results in increased expression of IL1RAP mRNA CTD PMID:27188386 zinc atom multiple interactions ISO RGD:732294 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of IL1RAP mRNA CTD PMID:16979875 zinc(0) multiple interactions ISO RGD:732294 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of IL1RAP mRNA CTD PMID:16979875
Biological Process cytokine-mediated signaling pathway ISO RGD:10791 1624291 (MGI:MGI:2179626, PMID:11880380) RGD MGI:MGI:2179626 , PMID:11880380 cytokine-mediated signaling pathway IEA GO:0004908 1600115 GO_REF:0000108 GOC GO_REF:0000108 inflammatory response IEA UniProtKB-KW:KW-0395 1600115 GO_REF:0000037 UniProt GO_REF:0000037 interleukin-2 biosynthetic process ISO RGD:10791 1624291 (MGI:MGI:2179626, PMID:11880380) RGD MGI:MGI:2179626 , PMID:11880380 interleukin-2 biosynthetic process IEA UniProtKB:Q61730 , ensembl:ENSMUSP000000938431600115 GO_REF:0000107 Ensembl GO_REF:0000107 interleukin-33-mediated signaling pathway ISO RGD:10791 1624291 (MGI:MGI:3764000 more ... RGD MGI:MGI:3764000 more ... interleukin-33-mediated signaling pathway IEA UniProtKB:Q61730 , ensembl:ENSMUSP000000938431600115 GO_REF:0000107 Ensembl GO_REF:0000107 interleukin-4 secretion ISO RGD:10791 1624291 (MGI:MGI:4353496, PMID:17675517) RGD MGI:MGI:4353496 , PMID:17675517 interleukin-4 secretion IEA UniProtKB:Q61730 , ensembl:ENSMUSP000000938431600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of dendrite development ISO RGD:10791 1624291 (MGI:MGI:5315316, PMID:22357843) RGD MGI:MGI:5315316 , PMID:22357843 positive regulation of interleukin-13 production ISO RGD:10791 1624291 (MGI:MGI:4353496, PMID:17675517) RGD MGI:MGI:4353496 , PMID:17675517 positive regulation of interleukin-13 production IEA UniProtKB:Q61730 , ensembl:ENSMUSP000000938431600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of interleukin-5 production ISO RGD:10791 1624291 (MGI:MGI:4353496, PMID:17675517) RGD MGI:MGI:4353496 , PMID:17675517 positive regulation of interleukin-5 production IEA UniProtKB:Q61730 , ensembl:ENSMUSP000000938431600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of interleukin-6 secretion ISO RGD:10791 1624291 (MGI:MGI:3764000, PMID:18003919) RGD MGI:MGI:3764000 , PMID:18003919 positive regulation of interleukin-6 secretion IEA UniProtKB:Q61730 , ensembl:ENSMUSP000000938431600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of NF-kappaB transcription factor activity ISO RGD:10791 1624291 (MGI:MGI:3764000, PMID:18003919) RGD MGI:MGI:3764000 , PMID:18003919 positive regulation of NF-kappaB transcription factor activity IBA MGI:MGI:104975 , PANTHER:PTN002628232 13792537 PMID:21873635 GO_Central positive regulation of NF-kappaB transcription factor activity IEA UniProtKB:Q61730 , ensembl:ENSMUSP000000938431600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of synapse assembly ISO RGD:10791 1624291 (MGI:MGI:5315316 more ... RGD MGI:MGI:5315316 more ... positive regulation of synapse assembly ISS UniProtKB:Q61730 1600115 GO_REF:0000024 UniProt GO_REF:0000024 positive regulation of synapse assembly IEA UniProtKB:Q61730 , ensembl:ENSMUSP000000938431600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of postsynaptic density assembly IEA UniProtKB:Q61730 , ensembl:ENSMUSP000000938431600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of postsynaptic density assembly ISO RGD:10791 1624291 (MGI:MGI:5315316, PMID:22357843) RGD MGI:MGI:5315316 , PMID:22357843 regulation of presynapse assembly IEA UniProtKB:Q61730 , ensembl:ENSMUSP000000938431600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of presynapse assembly ISO RGD:10791 1624291 (MGI:MGI:5315316, PMID:22357843) RGD MGI:MGI:5315316 , PMID:22357843 synaptic membrane adhesion IEA UniProtKB:Q61730 , ensembl:ENSMUSP000000938431600115 GO_REF:0000107 Ensembl GO_REF:0000107 synaptic membrane adhesion ISO RGD:10791 1624291 (MGI:MGI:5315316, PMID:22357843) RGD MGI:MGI:5315316 , PMID:22357843 trans-synaptic signaling by trans-synaptic complex IEA UniProtKB:Q61730 , ensembl:ENSMUSP000000938431600115 GO_REF:0000107 Ensembl GO_REF:0000107 trans-synaptic signaling by trans-synaptic complex ISO RGD:10791 1624291 (MGI:MGI:5315316, PMID:22357843) RGD MGI:MGI:5315316 , PMID:22357843 Cellular Component cytoplasm IDA 5508726 RGD glutamatergic synapse IEA UniProtKB:Q61730 , ensembl:ENSMUSP000000938431600115 GO_REF:0000107 Ensembl GO_REF:0000107 glutamatergic synapse ISO RGD:10791 1624291 (MGI:MGI:5315316, PMID:22357843) RGD MGI:MGI:5315316 , PMID:22357843 integral component of membrane IEA UniProtKB-KW:KW-0812 1600115 GO_REF:0000037 UniProt GO_REF:0000037 integral component of membrane IEA UniProtKB-KW:KW-0812 1600115 GO_REF:0000038 UniProt GO_REF:0000038 protein-containing complex IDA 5508726 RGD Molecular Function interleukin-1 binding TAS 633114 RGD interleukin-1 receptor activity IEA InterPro:IPR004074 1600115 GO_REF:0000002 InterPro GO_REF:0000002 interleukin-1 receptor activity IBA MGI:MGI:104975 , PANTHER:PTN002628236 13792537 PMID:21873635 GO_Central interleukin-1 receptor activity IEA UniProtKB:Q61730 , ensembl:ENSMUSP000000938431600115 GO_REF:0000107 Ensembl GO_REF:0000107 interleukin-1 receptor activity ISO RGD:10791 1624291 (MGI:MGI:2179626, PMID:11880380) RGD MGI:MGI:2179626 , PMID:11880380 interleukin-1 receptor binding TAS 633114 RGD interleukin-1 receptor binding IBA PANTHER:PTN002628236 , RGD:2893 13792537 PMID:21873635 GO_Central interleukin-1 receptor binding IPI RGD:2892 5508726 RGD interleukin-33 receptor activity ISO RGD:10791 1624291 (MGI:MGI:4353496, PMID:17675517) RGD MGI:MGI:4353496 , PMID:17675517 interleukin-33 receptor activity IEA UniProtKB:Q61730 , ensembl:ENSMUSP000000938431600115 GO_REF:0000107 Ensembl GO_REF:0000107 protein binding ISO RGD:10791 1624291 UniProtKB:P14719 more ... RGD MGI:MGI:1889886 more ... protein binding, bridging TAS 633114 RGD protein tyrosine kinase binding ISO RGD:10791 1624291 UniProtKB:Q64487 (MGI:MGI:5315316 , PMID:22357843) RGD MGI:MGI:5315316 , PMID:22357843
Gene-Chemical Interaction Annotations
